Trial Profile
Posaconazole for the prophylaxis of invasive fungal infection in patients receiving induction therapy for acute myeloid leukaemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidaemia
- Focus Therapeutic Use
- 29 Apr 2014 New trial record
- 10 Dec 2013 Results (n = 120) from two time periods (Jul2009-Jun2011 and Jul2011-Jun2013) presented at the 55th Annual Meeting and Exposition of the American Society of Hematology.